A selection of Companies Exhibiting
Click the Company Logo to find out more
The Diabetic Boot Company Limited
The Diabetic Boot Company owns the Pulse-Flow Pulseboot®, a new form of diabetic friendly footwear with integrated offloading capabilities and the patented Pulseflow technology which aids in the promotion of blood flow and improved circulation in one product. In the UK £650m a year is spent on diabetic foot ulcer treatment and subsequent amputations, however, many of them are avoidable given proper care and special diabetic footwear. Improving foot care and reducing the number of diabetic foot ulcers and amputations are key aims for health systems around the globe.
CE marked Patented $1,000,000,000 opportunity, supported by Global Experts in the field
De-risked investment opportunity; clear business model
Diabetes is growing exponentially; so are diabetic foot ulcers (DFU). Costly (~$32,000) to heal, leading to amputation in 20% of cases.
Pulseboot addresses 4 needs of these hard to heal wounds
- Looks like normal footwear (social stigma)
- Records patient compliance (improves healing)
- Pumps blood round the foot (improves oxygenation)
- Reduces pressure on wound during walking ( faster healing)
t1ps.com provides share tips and company analysis, specialising in identifying small cap growth companies. The team of analysts at t1ps.com have decades of City experience behind them and are seasoned finance professionals. Our analysts are not only well connected but have also learned from experience how to avoid the sort of mistakes less experienced investors might make.
Status Grand Prix
Status Grand Prix Engineering Ltd is a UK-registered company racing under a Canadian licence. Founded in 2005, it operates as a multi-faceted international motorsport team, dedicated to the top-level engineering and professional service required to succeed in motor racing’s biggest arenas. Status GP has a multi-year contract to operate a three-car team in the GP3 Series through 2015, having finished second in both the Drivers’ and Teams’ Championships in the inaugural 2010 season.
Square Mile magazine has been the City of London’s top luxury lifestyle publication for nine years. This monthly title is distributed to 52,000 affluent business people working in the financial services industries in the City, Mayfair and Canary Wharf. It is complimented by a fully interactive iPad edition, a weekly newsletter, http://www.squaremile.com and numerous City focused events.
Red Rock Resources plc
Red Rock Resources plc is a mineral exploration and production company primarily focussed on the discovery and development of gold. Its gold portfolio includes a producing mine in Colombia, an advanced exploration project in Kenya, and an early-stage exploration project in Ivory Coast – a country being hailed as the ‘next big thing’ in gold exploration. Red Rock invests in projects and opportunities where it can enhance the value of its assets through exploration, development and corporate transactions.
Minesite is the leading authority on mining news in the UK. Established in 1998, we bring a wealth of experience in mining and capital markets and this makes us the most trusted and respected name in the mining industry.
With a dedicated team of experienced and internationally-based writers and a readership of more than 25,000, Minesite puts the latest developments in mining in front of a sophisticated global audience. Minesite is the first choice for companies striving for quality coverage.
We have been running the Minesite Investor Forums for more than ten years and we are renowned throughout the industry for bringing companies and investors together. Companies present to an audience of over 150 institutional and heavyweight private investors, journalists and industry experts at our central London venue.
Oilbarrel.com is Europe’s leading website for detailed information about upstream mid tier and small cap oil and gas companies around the world. Editorially led, we believe our approach is unique in that comment is written by our own team of professional journalists
We do not republish content sourced from elsewhere on the internet or print media. Our core activity is putting under-covered companies in touch with under-informed investors.
Established in 2004, Oilbarrel’s regular investor conferences are renowned throughout the industry for bringing companies and investors together. Companies present to an audience of 200+ institutional and heavy weight private investors, journalists and industry experts at our central London venue
JNF Capital advises on Spread Bets and CFDs. JNF Capital are the only stockbroker that offers profit related charging. A managed futures trading service is also available.
Harriman House is the UK’s leading publisher of books on finance, investment and trading. Areas we cover include technical analysis of the financial markets, techniques and systems for traders, fundamental skills of investing, great investors and their life stories, alternative investing areas & business and economics. Our books are written by leading practitioners in their field and we publish to the highest production standards possible.
GECR is a leading independent equity research body that covers mid and small-cap companies. Our in-depth research is distributed to global institutional investors as well as our private investor base, consisting of more than 60,000 active private investors.
Beowulf Mining plc
Beowulf is AIM listed in London and the AktieTorget market in Stockholm.
With a portfolio of Swedish exploration Licences it is concentrating on its JORC compliant iron assets at Kallak and copper at Ballek. Well funded the company is actively drilling at both sites, extending its Licence areas and applied for a Mining Licence at Kallak.
Accendo Markets Ltd
Accendo Markets is an online trading services provider, offering CFDs, spread betting and forex to retail (private) clients. With Accendo Markets, you can access global financial markets at the touch of a button. You can also place orders over the telephone with your dedicated trader.
We provide equity research services, educational guides and organise
regular social excursions throughout the UK and beyond, allowing our
members to interact with other like minded people.
JPS Wealth Management
We provide an experienced wealth management service and offer specialist advice in a wide range of areas including Investment Planning, Retirement Planning, Inheritance Tax Planning.
Our Honest Foods
Our Honest Foods offers a way for regular office folk to keep those hunger grumbles away. We drop a wooden box full of top-notch British snacks into your office, allowing foragers to feast to their stomach’s content. We will then send regular refills, at your discretion but typically weekly, which will mean that your Honest Box never goes empty, and you never hungry.
Karelian Diamond Resources plc
Karelian Diamond Resources (“Karelian”) is a diamond exploration company focussed on Finland. Karelian has demonstrated that at 6.9 hectares it’s Seitaperä target is the largest known diamondiferous kimberlite discovered to date in Finland. The Company’s objective is to discover in Finland a world class diamond deposit comparable to those which have been found in similar geology in Russia.
Regency Mines Plc
Regency Mines Plc is a mining exploration and mineral investment company with agromineral interests in Sudan, nickel interests in Papua New Guinea and nickel and other mineral interests in Australia. Regency’s predominant Australian interests are in the Fraser Range, adjacent to Sirius’ Nova Deposit. The Company is also an investor in the DNi process – a revolutionary lateritic nickel treatment technology. This is a forward-thinking Company which looks for projects globally which have the possibility for large-scale discoveries, and ultimately, significant gains to investors.
Africa New Energies
Bringing together industry veterans with finance and mathematical geniuses, ANE boasts a state-of-the-art algorithm that challenges conventional methods of finding oil and gas. With top-notch surface exploration techniques ANE has managed to TRIPLE the probability of success of conventional methods for finding oil and gas. This revolutionary process is not only bound to reduce hydrocarbon exploration costs dramatically, but also – improve production and maximize oil recovery.
london Mining Plc
London Mining is an expanding producer of high specification iron ore concentrate for the global steel industry and is focused on identifying, developing and operating sustainable mines. London Mining commenced sales from its 100% owned Marampa Mine in Sierra Leone in 2012 producing 3.4Mwmt/a in 2013 and expanding to a capacity of 6.5Mwmt/a over the next few years. Marampa has sufficient resources to support a staged expansion to up to 20Mwmt/a. London Mining has also completed bankable feasibility studies outlining plans for a further 20Mwmt/a of iron ore production by developing mines in Greenland and Saudi Arabia.
Eurasia Mining (EUA)
‘Eurasia (AIM:EUA) is developing alluvial and bedrock platinum group metals (PGM) projects in Russia and the FSU. Of Eurasia’s two projects West Kytlim is key – mining license is imminent and platinum production may commence in 2015. Eurasia will redefine its business structure on the advent of platinum production, to include a development and production division alongside its exploration division.
Eurasia’s exploration focus is the Monchetundra project on the Kola Peninsula and is an open pittable hardrock PGM target. Eurasia continues to see increasing value in Russian gold projects and is working with business partners on near production and exploration opportunities.‘
Platinum Portfolio Builder
We build and manage property portfolios for people who want to invest in property, but who don’t have the time, knowledge or inclination to do it themselves. We offer market-leading returns to clients who have £100K plus to invest and who are unhappy with the poor returns, high fees and uncertainty typically associated with traditional investments and pensions.
Societe Generale Listed Products (SCGLY)
Societe Generale is one of the world’s largest issuers of Listed Products, with a 20 year track record of providing an outstanding trading service to retail, professional and institutional investors across the world. The huge diversity of Structured Products, Covered Warrants and Lyxor ETFs mean that investors of all types, ages and objectives can access the markets at a level of risk that suits them, with the transparency, flexibility and control that comes from being listed on the London Stock Exchange.
InterQuest has been trading since 2001, growing during this time to an AIM listed, £115 million Turnover Company.
InterQuest is a specialist recruitment Group, comprising a number of independent businesses that operate either in a single market sector, such as Financial Markets, Retail or Not for Profit, or within a clearly defined area of technology. Our sector and technology aligned businesses are augmented by others which provide services such as recruitment outsourcing and executive search spanning each of our niche focus areas.
London Stone Securities
We are an independent stock broking company based in the financial heart of the City of London, commonly known as the “Square Mile”. We are registered with Companies House in England and Wales (registration number 6464964) and we are also authorised and regulated by the Financial Conduct Authority 479827.
As an independent firm we are able to offer you a bespoke, personal service tailored to your individual needs. Whether you are an experienced trader or a complete novice, our team of advisory brokers will help you to achieve all of your investment objectives through timely and well researched trading ideas.
London Stone Securities, “Your Aspiration is our Motivation”
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV.
Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles.
Plethora Solutions Holdings Plc
Plethora Solutions is a speciality pharmaceutical company dedicated to the development and marketing of products for the treatment and management of urological disorders. The company’s principal product is referred to under its development name of PSD 502, a treatment remedy for male premature ejaculation. The diagnosis and treatment of urological conditions represents an expanding market with many poorly met medical needs that offer significant commercial potential for new pharmaceutical products and medical devices.
MoPowered is a ‘Software-as-a-Service’ (‘SaaS’) platform, launched in March 2012, which works with businesses of all sizes, to automate websites and enable mobile commerce. Key distribution partnerships with PayPal, WorldPay and MasterCard enable the Group to access the majority of UK merchants.
The software platform allows automated development of mobile sites rather than custom deployment with the corresponding time and cost advantages. The commercial model is predominantly based on long-term contracted, recurrent revenues.
MoPowered is well positioned to capitalise on the new types of shopping opportunities created by mobile devices. Retailers face significant challenges and are therefore outsourcing to expert mobile partners such as MoPowered. Management believes that half of the e-commerce market has online sales of less than £20m per annum and SaaS solutions are likely to be the best economic alternative for these merchants.
Binary.com is the premier trading platform for binary options on all financial markets.
At Binary.com we offer trades ranging from 15 seconds up to 365 days on Forex, Indices, Stocks, Commodities and global Sector Indices. Trades may be purchased with as little as £1 and clients are able to choose from a wide range of contracts that are suitable for both trending and flat markets. Our unique “fixed returns” service as well as the flexibility of selecting a different strike for each trade, means clients know exactly how much they stand to win or lose before they commit to a trade. There are no hidden risks or fees. No complicated trades. No stop-losses required. With Binary.com, clients are completely in control of their risk.
In addition, Binary.com also offers educational sessions on financial trading for free via online webinars.
The principals behind LendInvest come from top-tier backgrounds in law, property, banking and finance. LendInvest has been set up and is run day-to-day by people with real world lending experience. We have been actively lending in the UK mortgage market since late 2008. As a result we have refined our processes and now boast some of the most sophisticated fraud detection and underwriting processes in the market. Due to our well established footprint in the mortgage market, we generate substantial deal-flow (over L100m each month) which allows LendInvest to source the best lending opportunities for investors.
Avation Plc (LSE: AVAP)
Avation Plc is a rapidly growing aircraft lessor. As at January 2014 the Company has a fleet of 24 jet and turboprop aircraft that it leases to leading global commercial airlines including US Airways, Virgin Australia and Thomas Cook. Avation’s future growth is assured, through the delivery of seven (7) aircraft contracted to be delivered in 2014. In addition to this, the Company holds a further thirty two (32) options for aircraft to be delivered from 2015 onwards and also acquires aircraft already leased to airlines on an opportunistic basis.
Wealth Training Company LLP
Wealth Training Company LLP is the number 1 UK based investment training company since 1999. Our ‘Master Classes’ and training courses are the most popular of their kind in Britain and have generated vast numbers success stories and consistent praise from over 300,000 attendees and the investment industry.
Miraculins is a publicly traded, Canadian biotechnology company (TSX-V:MOM), focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs. The Company’s lead technologies are its point-of-care Scout DS® Non-Invasive Diabetes Test and PreVu® Non-Invasive Skin Cholesterol Test, both of which measure disease biomarkers in the skin within minutes without requiring needles, blood draw or fasting.
Scout DS® Diabetes Screening
The Miraculins Scout DS® is the first non-invasive diabetes testing system designed to provide a highly sensitive and convenient method for measuring diabetes related biomarkers in the skin, associated with abnormal blood sugar levels and oxidative stress. Unlike current testing methods, a Scout DS® test requires no needles or blood draw, no fasting, and takes only 90 seconds. This exciting new technology, which has been CE Marked and is officially registered with various Member States within the European Union, will be on display at the show with free testing available to delegates – sponsored by Master Investor. Please visit Booth # 6, 7 and 8. Miraculins is a publicly traded Canadian biotechnology company (TSX-V:MOM)
PreVu® Non Invasive Skin Cholesterol Test
The Miraculins PreVu® Test is a revolutionary new assessment technology for risk of coronary artery disease (CAD), that non-invasively measures cholesterol levels in a patient’s skin within minutes, painlessly and without the need for fasting. Elevated levels of skin cholesterol have been clinically shown to be associated with an increased risk of CAD. This exciting new technology, which has been CE Marked and is officially registered with various Member States within the European Union, will be on display at the show with free testing available to delegates – sponsored by Master Investor. Please visit Booth # 6, 7 and 8. Miraculins is a publicly traded Canadian biotechnology company (TSX-V:MOM)
Kris Kon is Europe’s largest direct provider of oil and gas rights (Working Interests) from the U.S. Kris Kon’s projects and the investors’ ownership/accounts are monitored continuously by chartered accountants in the U.S. Kris Kon has offices in Denmark, Sweden, The Netherlands, Luxembourg, Spain and Texas, USA.
Central Markets Ltd
Central Markets London (Ltd) is an independent and privately owned stockbroker, based in the City of London, authorised and regulated by the Financial Conduct Authority (Company No. 473312)
At Central Markets we offer traditional stock broking services to our clients from advising on buying and selling of individual stocks, to trading the market through Contracts for Difference and Foreign Exchange. Clients are able to benefit from a full advisory service to an efficient execution only service, depending on the needs of the client.
Another core area that Central Markets specialises in is Private Equity. The Private Equity Division of Central Markets, identifies developing business that are below the radar of institutional investors and offer compelling opportunities for investment.
TMT Investments PLC (ticker: TMT.L) is an AIM-traded venture capital firm, focused on earlier-stage, high-growth internet-based companies. Led by a deeply experienced management team, since IPO in December 2010 it has made 30 investments and conducted 3 exits, including the sale of task management app Astrid to Yahoo! in 2013. A number of investments have been significantly revalued in the last two years. TMT provides a rare opportunity for private investors to invest in hard to access, privately held internet companies.
FXCM Inc. (NYSE: FXCM) is a global online provider of foreign exchange (forex) trading and related services to retail and institutional customers world-wide.
At the heart of FXCM’s client offering is No Dealing Desk forex trading. Clients benefit from FXCM’s large network of forex liquidity providers enabling FXCM to offer competitive spreads on major currency pairs. Clients have the advantage of mobile trading, one-click order execution and trading from real-time charts. FXCM’s U.K. subsidiary, Forex Capital Markets Limited, also offers CFD products with no re-quote trading and allows clients to trade oil, gold, silver and stock indices along with forex on one platform. In addition, FXCM offers educational courses on forex trading and provides free news and market research through DailyFX.com.
Port Erin Bio Pharma
Port Erin creates value for shareholders through investing in companies that have the potential to generate substantial revenues through the development of biopharmaceutical drugs. The group is beginning to capitalise on the new wave of modern medicines which pharmaceutical companies are producing. These opportunities will only advance further with time and Port Erin, directed by Jim Mellon, is in a prime position to exploit this.
Learn to Trade
Welcome to the first step towards your Richer Life.
We are Europe’s largest and most successful trader training organisation, with a 10 year history of major awards for service and quality. We have trained over 200,000 people worldwide to trade the foreign exchange and stock markets, and we can help YOU to embark upon a new and exciting career as a private trader.
Arrowhead Research Corporation
Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and partner-based programs in obesity and oncology.
Small Cap Club
The Small Cap Club provides regular networking events for key participants, leaders and advisors of quoted small capcompanies in the UK. Regular meetings are organised where members can meet to network in a relaxed and informal environment with guest speakers. Membership is via application or invitation. Members are invited to nominate suitable candidates for membership.
Liquid Investments provides global financial solutions allowing institutional and private investors to accumulate wealth by utilising precisely applied Modern Portfolio Theory, and implementing a strategy of diversification to safe, secure alternative assets in emerging markets. The company specialises in ethically grown commodities, providing investors with significant returns based on farmland values, as well as an annual income from the production and sale of multi-use commodity based products.
Webis Holdings Plc (AIM:WEB)
Webis Holdings plc is an AIM listed company specialising in global gaming. The company owns two complementary licenced entities with operation centres in California and Kentucky: WatchandWager, a totalisator betting website and portal which provides easy access to a large number of global racetrack betting pools, including the United States, Hong Kong and France, and; Cal Expo, a Sacramento based harness racetrack that races twice-weekly from October through to May.
Manx Financial Group (AIM: MFX)
Manx Financial Group PLC offers retail and commercial banking services, payment solutions, wealth management, general insurance and life insurance, through its wholly owned subsidiaries Conister Bank Limited, Conister Card Services Limited, and Edgewater Associates Limited.
ECR Minerals Plc
ECR is a mineral exploration and development company with, among other interests, the right to earn a 50% interest in the Itogon gold project in the Philippines. ECR also has a 100% interest in the SLM gold project in La Rioja Province, Argentina. In addition, ECR is reviewing potential new investments on a highly selective basis, with a concentration on precious, base and strategic metals projects.
Condor Gold PLC (LSE: CON)
Condor Gold in a UK based AIM listed company. It has 2.4M oz gold at 3.8g/t at its La India Project in Nicaragua which includes 1.1M oz in the Indicated category and 1.2M in the Inferred category. Condor completed a PEA in March 2013 and is due to produce a PFS in the coming weeks. The PFS will focus on a base case open pit using 840,000 oz gold at 3.1g/t in the indicated category in La India open pit, aimed at circa 80,000 oz gold production p.a. There will be two PEAs. One PEA will show the upside of adding two feeder pits with production increasing to circa 100,000 oz gold pa and the second PEA will show the upside of adding underground production with total production guidance of 130,000 oz gold pa.
Fundsmith is a fund management company established in 2010 by Terry Smith. The business is 100% owned and controlled by its partners, who have worked closely together over many years, and is headquartered in London with an office in Connecticut, USA. The investment process of the Fundsmith Equity Fund will be the only equity fund strategy that we employ and the Fundsmith Equity Fund is the main vehicle for Terry’s own investments.
Conroy Gold and Natural Resources plc
Conroy Gold and Natural Resources (“Conroy”) is an Irish based resource company exploring and developing gold and other projects in Ireland. Conroy has under licence the entire thirty mile gold trend which it has discovered in the Longford-Down Massif in Ireland. Conroy has discovered a series of gold targets along the trend and is working towards developing a gold mine on 20 per cent of one of these targets – Clontibret in Co. Monaghan, where positive technical and financial scoping studies have been completed by independent consultants – Tetra Tech.
GenSignia, Inc. was founded in 2011, based on leading academic research, to develop new molecular diagnostic techniques for the earlier detection of cancers. A privately-held company, its discoveries show that it is possible to detect signatures of cancer in blood through the identification of tiny nucleic acid fragments called miRNAS. Based on promising data, the company intends to build strong clinical test platform that will enable earlier diagnosis, and therefore improve survivability, of the most prevalent, lethal cancers, such as lung cancer.
Headquartered in San Diego, California, Trovagene is developing its patented technology for the detection of transrenal DNA and RNA, short nucleic acid fragments, originating from normal and diseased cell death that cross the kidney barrier and can be detected in urine. Trovagene has a strong patent position as it relates to transrenal molecular testing and has U.S. and European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing.
Optiva Securities (“Optiva”) is a growing and dynamic corporate advisory and private client stockbroking business, which can provide access to capital for companies that can demonstrate the potential to make substantial capital gains for investors.
We can also offer to certain private clients for whom it is suitable; In-House Placings, where Optiva Securities acts as corporate broker to the company as well as providing a conduit to External Placings. Optiva also offer private clients’ investments into AIM and Fully Listed companies via their ISAs, SIPPs and when available through EIS schemes.
KILLIK & Co
Killik & Co is a financial services firm with a stock broking heritage which offers financial and securities advice and execution, as well as investment management across the whole market. We are an independently owned business and are not tied to any particular product providers. We can therefore consider the widest range of investment options for our clients’ needs.
As a leading wealth management provider, we believe in providing comprehensive and independent financial planning services. Our private wealth management planners are holistic in their approach and cover all aspects of your financial matters from pensions and annuities to inheritance tax planning and trusts to ensure that you have the correct financial architecture in place to meet your wealth management planning objectives.
The Killik & Co partnership was founded in 1989 and operates from nine branch offices in, and around, Greater London and one international branch in Dubai. We currently look after approximately £3.3 billion on behalf of over 25,000 private clients.
West African Minerals Corp
West African Minerals Corporation (WAFM) is an AIM-listed iron ore mining and exploration group with one of the largest land positions in Cameroon considered prospective for high-tonnage, hematite-rich direct shipping ore (DSO). Through its wholly-owned subsidiary CMC SA, WAFM owns 100% interest in six exploration permits spanning the coastal vicinity of the deep water port of Kribi, to the southeast adjacent to such advanced projects as Mbalam.
A large-scale exploration programme is currently underway to outline the near-term potential of WAFM’s coastal permits towards production in relatively short time and at low cost, in addition to establishing large volume resources close to the proposed south Cameroon rail corridor. The regional prospectivity of southern Cameroon as the next major iron ore frontier is exemplified by increasing exploration activity and investment by global majors and diversified mining companies.
Union MedTech is focused on acquisitions in the medical technology sector, excluding pharmaceuticals. Its goal is to find medical devices, diagnostics and other healthcare products and services that, although capable of generating substantial profits, need assistance to bring them to market or expand their markets internationally. The company works with inventors and small companies that have created high value technologies which have the power to transform lives, yet have struggled to achieve international market penetration due to lack of capital, expertise or resources.
Fastnet Oil & Gas plc
Fastnet Oil & Gas plc is an AIM quoted oil and gas exploration company focused on identifying early stage exploration and appraisal opportunities in Offshore Africa and Ireland. Fastnet’s aim is to assemble a portfolio of high impact conventional oil and gas assets in areas that have been underexplored by industry majors. The Company has a highly experienced management team with a proven track record of generating significant shareholder value in the oil and gas industry.
London’s Air Ambulance
London’s Air Ambulance is the Charity that delivers an advanced trauma team to critically injured people in London. The service provides pre-hospital medical care at the scene of the incident and serves the 10 million people who live, work and commute within the M25.
Based at the Royal London Hospital and founded in 1989, the service is unique in that it operates 24/7, with the helicopter running in daylight hours and rapid response cars taking over at night.
The Team, which at all times includes a Senior Trauma Doctor and a specially trained Paramedic, perform advanced medical interventions, normally only found in the Hospital Emergency Department, in time critical, life threatening situations. Missions commonly involve serious road traffic collisions, falls from height, industrial accidents, assaults and injuries on the rail network.
London’s Air Ambulance has an international reputation for clinical excellence and delivers pioneering procedures which have been adopted across the world.
Trovagene is a diagnostics company with headquarters in San Diego, California. It holds intellectual property around the discovery that cell-free DNA, RNA and other types of nucleic acids pass through the kidney into the urine. These “Transrenal Nucleic Acids” can be diagnostic of diseases such as cancer and infection. Through this revolutionary technology, Trovagene is setting out to change the way medicine is practiced, through simple, non-invasive sampling and analysis of these nucleic acids. This can ultimately lead to earlier detection, more effective treatment monitoring, and better management of serious illnesses.
Summit (Oxford) Limited
Summit Corporation is a UK company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical needs. Its first area of focus is Duchenne Muscular Dystrophy (DMD), a fatal genetic muscle wasting disease for which there is currently no cure. DMD has an incidence of 1 in 3,500 and the patient population in the developed world is estimated to be 50,000. Summit’s programme is a potential disease-modifying approach that is expected to treat all DMD patients, regardless of the genetic fault causing their disease. Its second area of focus is Clostridium difficile infection (CDI), a potentially fatal illness that is a major healthcare issue in hospitals and long-term care homes, and increasingly in the wider community. It is estimated that there are currently 900,000 cases across Europe and North America per annum. The rise means CDI has a high economic burden with the annual cost of care in Europe and North America estimated to be in excess of $7 billion.
EMED Mining is a minerals development company, currently focussed on bringing the Rio Tinto copper mine in Spain back into production. Rio Tinto’s initial base case production rate is 37,000 tonnes per annum by the end of 2015, with production expected to commence in 2014 and plant construction expected this year. Significant expansion plans are also being made, focused on re-establishing Rio Tinto as a mining field with several mines operating around a central processing plant. With the company’s target case net present value for Rio Tinto being up to $1.3 billion (£820 million) there looks to be significant upside to the current market cap of £123 million.
Ariana Resources PLC
London-listed Ariana Resources (AIM: AAU) is a gold and silver mining development company with near-term production potential in Western Turkey. The Global JORC resource stands at 1,540,000 oz Au. Ongoing exploration is fulfilled through our own work in western Turkey, via joint venture (Eldorado Gold) and strategic investment (Tigris Resources). Ariana is spearheaded by an experienced management team, which aims to discover and develop new gold mines.
Based in Oxford and Newcastle, e-Therapeutics is a drug discovery company, with a pipeline of two drug candidates. ETS2101 is currently in Phase I trials for the treatment of primary and secondary brain cancer in the UK and US, the results of which are expected in the fourth quarter of 2013 and first quarter of 2014. Aside from its primary market, there have been signs that this drug may prove effective against other forms of cancer. The company’s second drug candidate, ETS6103, is used to treat depression and is scheduled to being Phase IIb trials in the second quarter of 2013, having shown encouraging results in a Phase IIa study when it was compared with the approved anti-depressant amitriptyline. The results of the next round of trials is due in the second quarter of 2014.
Plastics Capital Plc
Plastics Capital is a specialist plastics products manufacturer focused on proprietary products for niche markets. The Group has five factories in the UK, two in China, one in Thailand and sales offices in the USA, Japan, India and China. Plastics Capital was incorporated in December 2002 and was listed on the AIM market in December 2007.
Currently approximately 40 per cent of sales are exported to over 80 countries worldwide and production is concentrated in the UK where significant engineering know-how and automation underpins the Group’s competitiveness.
The Group’s corporate strategy is to build shareholder value by continuing to grow its key businesses organically and through value enhancing acquisitions
Founded in 1998, Alliance Pharma is a medical science company, whose principal activity is the acquisition, licensing and marketing of mature pharmaceutical products. The company has purchased the rights to over 50 established products across a wide range of therapy sectors, including Dermatology, Oncology and Nutrition. The group primarily targets the prescription market and its products are supplied directly to hospitals as well as pharmaceutical wholesalers. Its key treatments include Deltacortril, acquired from Pfizer in 2006, which is used against inflammatory and allergic disorders and anti-clotting agent Nu-Seals, purchased from Lilly in 2002.